Try our mobile app

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

Tilray, Inc. operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.
  • Current market environment: negative. Prices of production are 4.2% lower compared to the last 12 months (LTM)
  • Prices of production are at 2.4% percentile over the past 5 years, adjusted for inflation (are close to minimun)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 83.4% (LTM), projected 53.1%
  • Share price is -2.4% higher than minimum and 92.4% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-0.4x vs
    )
  • The company is undervalued by EV / projected EBITDA multiple compared to target level (
    vs
    )

Key Financials (Download financials)

Ticker: TLRY
Share price, USD:  (-6.4%)0.4453
year average price 1.4512  


year start price 1.7200 2024-04-18

max close price 2.4700 2024-04-30

min close price 0.4563 2025-04-08

current price 0.4453 2025-04-17
Common stocks: 460 254 275

Dividend Yield:  0.0%
FCF Yield LTM / expected: 83.4% / 53.1%
EV / LTM EBITDA: -0.4x
Production prices change from LTM: -4.2%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 205
Net Debt ($m): 57
EV (Enterprise Value): 262
EBITDA LTM ($m): -724
EV / LTM EBITDA: -0.4x
Price to Book: 0.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2025-04-10seekingalpha.com

Tilray: Sell Before Potential Reverse Split

2025-04-09seekingalpha.com

Tilray: Q3 Earnings Could Be The Inflection Point It Needs

2025-04-08seekingalpha.com

Tilray Brands, Inc. (TLRY) Q3 2025 Earnings Call Transcript

2025-04-08proactiveinvestors.com

Tilray shares sink after quarterly revenue falls short of estimates

2025-04-08zacks.com

Tilray Brands, Inc. (TLRY) Reports Q3 Loss, Lags Revenue Estimates

2025-04-05fool.com

Is Tilray Brands a Millionaire Maker?

2025-03-27invezz.com

Tilray Brands stock price has crashed: time to buy the dip?

2025-03-21zacks.com

Tilray Brands, Inc. (TLRY) Laps the Stock Market: Here's Why

2025-03-16seekingalpha.com

Tilray Brands Is Now A Strong Buy

2025-02-18invezz.com

Tilray stock price crashes below $1: buy the dip or sell the rip?
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company